← Scoopfeeds — Intelligent news, curated.
Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics
business

Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics

Yahoo Finance · Jun 22, 2026, 2:23 PM · Also reported by 4 other sources

Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics

Read full story on Yahoo Finance → More top stories

Also covered by

Bloomberg Markets AbbVie to Buy Apogee Therapeutics for $10.9 Billion STAT News STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal Investing.com AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push Investing.com Why is Apogee Therapeutics stock surging today?

More in business

Investing.com
Nektar Therapeutics chief R&D officer sells $336,211 in stock
Investing.com
Sr. VP Jackson Noel sells $67,406 of Consumer Portfolio Services stock
Investing.com
Anterix chief reg & comm officer sells $7.5m in company stock
Investing.com
US judge blocks subpoenas to Minnesota officials in DOJ immigration probe
Bloomberg Markets
Morgan Stanley's Gower: Fed Holding Rates Through '26
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop